Biofrontera is an international biopharmaceutical company specializing in the development and commercialization of a platform of pharmaceutical products for the treatment of dermatological conditions and diseases caused by exposure to sunlight that results in sun damage to the skin. Co.'s approved products focus on the treatment in the U.S. and Europe of actinic keratoses, which are skin lesions that can sometimes lead to skin cancer, as well as the treatment of basal cell carcinoma in the European Union.
  • TickerB8F
  • ISINDE0006046113
  • SectorPharmaceuticals & Biotechnology
  • CountryGermany

ResearchPool Subscriptions

Get the most out of your insights

Get in touch